Luke S. Howard
Expertise in
4
conditions

Luke S. Howard

Du Cane Road, 
London, ENG, GB 
Expertise in
4
conditions
Du Cane Road, 
London, ENG, GB 

Overview

Luke Howard practices practicing medicine in London, United Kingdom.

Mr. Howard is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Pulmonary Embolism, and Cerebral Hypoxia.

He is actively involved in clinical research, co-authoring 198 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Du Cane Road, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
Enrollment Status: Terminated
Publish Date: June 08, 2026
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
Hypoxemia, Dyspnea, and Exercise Tolerance in Patients With Pulmonary Arteriovenous Malformations
Hypoxemia, Dyspnea, and Exercise Tolerance in Patients With Pulmonary Arteriovenous Malformations
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Procedure, Other
Study Phase: Not Applicable
What is the Effect of Intravenous Iron Supplementation on Cardiopulmonary Haemodynamics, Exercise Capacity and Quality of Life in Patients With IPAH and Iron Deficiency?
What is the Effect of Intravenous Iron Supplementation on Cardiopulmonary Haemodynamics, Exercise Capacity and Quality of Life in Patients With IPAH and Iron Deficiency?
Enrollment Status: Completed
Publish Date: March 07, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

198 Total Publications

Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertension.
Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertension.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026

Frequently Asked Questions about Luke S. Howard

Is Luke S. Howard a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Luke S. Howard is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Luke S. Howard participate in research or clinical trials?

Yes. Luke S. Howard has published 198 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Luke S. Howard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Howard's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile